Claire's filed for Chapter 11 bankruptcy in August 2025, the chain's second bankruptcy filling in seven years.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
高シグナルの見出しのみ — マクロイベント、決算、M&A、規制。リスト記事とアナリストのクリックベイトはデフォルトでフィルタ。1時間ごとに更新。
Claire's filed for Chapter 11 bankruptcy in August 2025, the chain's second bankruptcy filling in seven years.
DHR's Biotechnology segment posts 7% core revenue growth as bioprocessing demand stayed strong and equipment orders jumped despite headwinds.
The president’s financial disclosures reveal several trades in UnitedHealth and other insurers as the government set Medicare rate policies.
Looking past stocks because they trade at high trailing earnings multiples can be a costly mistake for investors.
Pharmacy benefit managers (PBMs) sit at the chokepoint of U.S. drug distribution. They negotiate rebates, design formularies, adjudicate claims, and steer patient adherence. Modern artificial intelligence (AI) is designed to compress each of these high-volume, rules-driven processes. As autonomous prior authorization, real-time formulary optimization, and AI-driven rebate analytics scale, the Big Three PBMs face a ... AI Is Coming for Pharmacy Benefit Managers: Potential Winners and Losers
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
A licensing agreement with Centric Brands will scale the retailer’s presence across partners, including Walmart, Kohl’s and CVS and will push the brand into new categories.
Over the past year, many CVS Health Corporation ( NYSE:CVS ) insiders sold a significant stake in the company which may...
We recently published Jim Cramer’s Latest Thoughts On Cisco, NVIDIA & Other AI Stocks. CVS Health Corp. (NYSE:CVS) is one the stocks discussed by Jim Cramer. Health insurer CVS Health Corp. (NYSE:CVS) is another stock that popped on Jim Cramer’s radar. The shares are up by 58.6% over the past year and by 19.7% year-to-date. […]
CVS Health’s first quarter results drew a significant positive market reaction, with performance driven by disciplined cost management, margin expansion, and continued improvement at Aetna. Management credited strong execution in medical cost containment and operational streamlining, particularly within the Health Care Benefits segment, as key factors. CEO David Joyner stated, “We are driving improved results at Aetna, while removing friction for members and providers.” Pharmacy & Consumer Welln
CVS Health (NYSE:CVS) has agreed to sell its Omnicare long-term care pharmacy business to GenieRx Holdings, with the transaction now approved. The company has also introduced CVS Air Response, a drone-enabled healthcare logistics and emergency support network built with SkyfireAI and Thales Aerospace. These moves reflect a refocus on core operations and new delivery channels for pharmacy and healthcare services. For investors tracking NYSE:CVS, these announcements come alongside recent...
Investors received two reminders of how well the company did in its first quarter.
The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.16%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.87%. June E-mini S&P futures (ESM26 ) fell -0.16%, and June E-mini Nasdaq futures...
NVIDIA, Mastercard and AbbVie headline Zacks' top stock reports, with AI growth, payment trends and drug launches in focus.
With an annual dividend yield of 2.88%, CVS Health Corporation (NYSE:CVS) is included among the 12 Best Blue Chip Dividend Stocks to Buy Now. America’s leading health solutions company, CVS Health Corporation (NYSE:CVS) provides advanced health care from pharmacy services and health plans to health and wellness. On May 8, Wells Fargo analyst Stephen Baxter slightly raised […]
CVS Health Corporation (NYSE:CVS) is one of the Best Undervalued Stocks to Buy Under $100. On May 5, the company announced that its pharmacy benefit arm is updating its commercial formularies effective July 1, 2026. This shift is aimed at lower-cost biosimilars over brand-name reference drugs. Management noted that the most prominent change includes replacing […]
The healthcare giant's stock is up after it posted another solid quarter, which showed a big improvement in its bottom line.
More than 20 years after it redefined fast shipping, Amazon is preparing to raise the bar on consumer expectations again by offering to fulfill customers' most urgent product needs in a half-hour or less for an extra fee. The company, which revolutionized online shopping in 2005 with two-day deliveries for Prime members, is rapidly opening small order-processing hubs in dozens of U.S. and foreign cities to cater to shoppers who can't or don't want to wait for cough medicine to relieve flu symptoms or tomatoes for tonight's dinner salad. The ultrafast service, called Amazon Now, first launched in India last June.
CVS Health (NYSE:CVS) expanded its MinuteClinic partnership with Hartford HealthCare to offer adult primary care at all Connecticut locations. Aetna Better Health, a CVS Health business, is providing funding to community health initiatives in Missouri focused on underserved populations. For investors tracking NYSE:CVS, these updates sit alongside a share price of $92.22 and strong recent momentum, with the stock up 12.4% over the past week and 16.2% over the past month. Returns of 15.1%...
CVS Health (CVS) shares have reclaimed their 50-day moving average and are challenging their all-time high around $95 following an eight-month consolidation period. The stock currently maintains a 72% “Buy” technical opinion from Barchart, signaling strong alignment across short, medium, and long-term timeframes. This level for that indicator has been...
CVS Health (NYSE:CVS) raised its full-year 2026 adjusted earnings outlook after reporting stronger first-quarter results, with management citing improved performance at Aetna, continued execution at Caremark and resilient pharmacy operations. On the company’s first-quarter earnings call, David Joyn
CVS Health Corporation (NYSE:CVS) is one of the stocks Jim Cramer shared his thoughts on as he discussed Big Tech’s AI spending. Cramer discussed the company’s “great” quarter during the episode, as he said: In Friday night’s game plan, I told you to expect a great quarter from CVS Health, and that’s exactly what we […]
We recently published Jim Cramer Said Sandisk Stock Performance is Befuddling & Discussed These 17 Stocks. CVS Health Corporation (NYSE:CVS) is one of the stocks discussed by Jim Cramer. CVS Health Corporation (NYSE:CVS) continues to be favored by Jim Cramer in the pharmaceutical retailer space. Its shares are up by 30% over the past year […]
To understand whether CVS Health stock might still offer value at around US$87.36, you need to know how that price compares with what the business could be worth using different valuation checks. Recent share price moves have been meaningful, with the stock showing returns of 4.9% over 7 days, 11.7% over 30 days, 9.0% year to date, 33.5% over 1 year, 42.3% over 3 years and 22.4% over 5 years, which can change how investors view both opportunity and risk. Alongside these returns, CVS Health...
CVS Health (NYSE:CVS) is rolling out major biosimilar formulary updates that are expected to affect prescription choices and costs across its pharmacy network. The company is expanding acceptance of WIC benefits statewide in Rhode Island for infant formula, broadening access for eligible families. CVS Health is adding new community partnerships and AI-driven initiatives focused on affordability, nutrition, and local health support. For investors tracking NYSE:CVS, these moves sit alongside...
The most significant insight currently obscured by CVS Health's (CVS) headline revenue growth is a high-stakes transition: the company is attempting to use a temporary surge in insurance profitability to outrun the structural margin pressures facing its pharmacy benefit management (PBM) business.
Knorr-Bremse (ETR:KBX) opened 2026 with what CEO Marc Llistosella described as the company’s “best first quarter in the past 5 years,” citing margin recovery in the commercial vehicle business and a record order backlog in its rail division. Management also reiterated its full-year guidance, while n
The ubiquitous pharmacy retailer crushed first-quarter analyst estimates.
Health care stocks were higher late Wednesday afternoon, with the NYSE Health Care Index increasing